超声检出推荐活检甲状腺结节的比率:所有指征都相同吗
该回顾性观察队列研究纳入2017至2019年在一家三级学术中心接受首次专门甲状腺超声的1739例成人,按转诊指征分组比较结节检出率及推荐活检率。结果显示仅27%的超声发现推荐活检的结节,近40%未发现结节;因其他影像偶然发现转诊者结节检出率最高(94%),压迫症状和代谢症状最低。
要点
- 1739例首次甲状腺超声中仅27%发现推荐活检的结节,近40%未发现任何结节。
- 因其他影像偶然发现转诊者结节检出率94%,高于可疑可触及结节55%、压迫症状39%、代谢症状43%(p < 0.05)。
- 偶然发现结节者推荐活检率55%,高于可疑可触及结节21%、压迫症状6%、代谢症状10%。
核心结论
- 所有新做的专门甲状腺超声中仅约四分之一发现推荐活检的结节,近40%未发现结节;因可疑可触及结节行超声者仅55%发现结节,压迫症状和代谢症状的结节检出率最低。
- 作者认为,明确甲状腺超声的开单指征有助于减少不必要的医疗利用和潜在过度治疗。
研究设计与样本
- 回顾性观察队列研究,纳入2017至2019年在一家三级学术中心接受首次专门甲状腺超声的成人(≥18岁)共1739例。
- 转诊指征分为可疑可触及结节、压迫症状、代谢症状、高危因素筛查、其他影像偶然发现随访及多因素组合。
- 采用单独逻辑回归模型分析发现任何结节及发现推荐活检结节的相关因素。
主要发现
- 最常见转诊指征为可疑可触及结节(40%),其次为偶然影像发现(28%)、压迫症状(13%)、组合因素(11%)、代谢症状(6%)、高危因素(2%)。
- 总体62%的超声发现结节;偶然发现组结节检出率最高(94%),可疑可触及结节组55%、压迫症状组39%、代谢症状组43%(p < 0.05)。
- 仅27%的超声发现推荐活检的结节;偶然发现组推荐活检率最高(55%),可疑可触及结节组21%、压迫症状组6%、代谢症状组10%。
- 与发现推荐活检结节相关的因素类似。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: The use of thyroid ultrasound increases yearly, adding to costs and overdetection of clinically irrelevant nodules. We investigated which indications most commonly prompt referral for thyroid ultrasound and the diagnostic utility by indication. Methods: We performed a retrospective observational cohort study of adults (≥18 years) undergoing an initial dedicated thyroid ultrasound between 2017 and 2019 at a tertiary academic center. Indicated reasons for referral were categorized into suspected palpable nodule (SPN), compressive symptoms (CS), metabolic symptoms (MS), screening due to high-risk factors, follow-up of incidental finding on other imaging, and combination of factors. Percentage of ultrasounds with an identifiable nodule and with a nodule recommended for biopsy was compared by indication. Separate logistic regression models were used to identify factors associated with finding any nodule and a biopsy-recommended nodule. Results: Among the 1739 patients included, the most common indication for thyroid ultrasound was SPN (40%), followed by incidental imaging (28%), CS (13%), combination (11%), MS (6%), and high-risk factors (2%). Overall, 62% of ultrasounds identified a nodule. Ultrasounds performed for incidental findings had the highest rate of nodule identification (94%), compared with 55%, 39%, and 43%, for SPN, CS, and MS, respectively (p < 0.05). Only 27% of ultrasounds identified a biopsy-recommended nodule. Nodules found incidentally had the highest rate of biopsy-recommended nodules at 55%. Rates of biopsy-recommended nodules for SPN, CS, and MS were 21%, 6%, and 10%, respectively. Logistic regression demonstrated that compared with patients referred for an SPN, those with incidental nodules were 10 times more likely to have a nodule found on ultrasound (odds ratio [OR] = 10.6 [CI 7.0-16.0]), while those referred for CS were half as likely to have a nodule (OR = 0.5 [CI 0.4-0.7]). Similar factors were associated with identification of biopsy-recommended nodules. Conclusions: Of all new dedicated thyroid ultrasounds, only a quarter find biopsy-recommended nodules, and nearly 40% do not identify a nodule at all. Notably, only 55% of ultrasounds done for SPN found a nodule. Ultrasound for CS and MS had the lowest rates of detecting nodules. Providing clear guidance on when to order thyroid ultrasounds can help reduce unnecessary health care utilization and potential overtreatment.
引用
- Kennedy E, Zhang Y, Qadadha Y, et al. Rates of Detecting Thyroid Nodules Recommended for Biopsy with Ultrasound: Are All Indications Equal? Thyroid. 2023. PMID: 37981778. doi:10.1089/thy.2023.0234
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。